1. Home
  2. MLSS vs KPTI Comparison

MLSS vs KPTI Comparison

Compare MLSS & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Milestone Scientific Inc.

MLSS

Milestone Scientific Inc.

HOLD

Current Price

$0.40

Market Cap

42.6M

Sector

Health Care

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$1.76

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLSS
KPTI
Founded
1989
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
42.6M
47.6M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
MLSS
KPTI
Price
$0.40
$1.76
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$1.00
★ $16.00
AVG Volume (30 Days)
65.1K
★ 1.3M
Earning Date
05-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
$8,973,982.00
★ $146,067,000.00
Revenue This Year
$12.64
N/A
Revenue Next Year
$8.99
$22.36
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 3.99
0.57
52 Week Low
$0.22
$1.24
52 Week High
$0.60
$10.99

Technical Indicators

Market Signals
Indicator
MLSS
KPTI
Relative Strength Index (RSI) 44.26 35.05
Support Level $0.24 $1.24
Resistance Level $0.41 $2.16
Average True Range (ATR) 0.04 0.15
MACD -0.00 0.13
Stochastic Oscillator 29.62 73.91

Price Performance

Historical Comparison
MLSS
KPTI

About MLSS Milestone Scientific Inc.

Milestone Scientific Inc develops and commercializes proprietary computer-controlled drug delivery systems designed to enhance the safety, precision, and patient experience associated with subcutaneous injections and fluid aspiration procedures. The company's core technology platform, Dynamic Pressure Sensing (DPS) Technology, controls flow rate and measures pressure at the needle tip in real time. DPS Technology is incorporated into both the company's dental and medical products and supports clinical applications, including local anesthesia delivery, epidural space identification in regional anesthesia procedures, and intra-articular joint injections. It operates in two segments: Dental, which markets and sells its dental products, and Medical, markets and sells its medical products.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: